Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

Clinical trial NCT01367275 · TERMINATED

Trial details

NCT number: NCT01367275
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Colorectal Adenocarcinoma

Start date: 2011-08-01
Primary completion: 2013-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.